| Symbol |
Name |
|
AGER
|
advanced glycosylation end product-specific receptor
|
|
BST1
|
bone marrow stromal cell antigen 1
|
|
C3
|
complement component 3
|
|
CACNA1A
|
calcium channel, voltage-dependent, P/Q type, alpha 1A subunit
|
|
CD1D
|
CD1d molecule
|
|
CD55
|
CD55 molecule, decay accelerating factor for complement (Cromer blood group)
|
|
CD59
|
CD59 molecule, complement regulatory protein
|
|
CR1
|
complement component (3b/4b) receptor 1 (Knops blood group)
|
|
CRP
|
C-reactive protein, pentraxin-related
|
|
CXCL8
|
chemokine (C-X-C motif) ligand 8
|
|
ECI2
|
enoyl-CoA delta isomerase 2
|
|
EPOR
|
erythropoietin receptor
|
|
GCH1
|
GTP cyclohydrolase 1
|
|
GDF15
|
growth differentiation factor 15
|
|
GHRL
|
ghrelin/obestatin prepropeptide
|
|
HLA-DQA1
|
major histocompatibility complex, class II, DQ alpha 1
|
|
HLA-DQB1
|
major histocompatibility complex, class II, DQ beta 1
|
|
HLA-DRB1
|
major histocompatibility complex, class II, DR beta 1
|
|
HMGA2
|
high mobility group AT-hook 2
|
|
IL6
|
interleukin 6
|
|
JAK2
|
Janus kinase 2
|
|
KCNA1
|
potassium channel, voltage gated shaker related subfamily A, member 1
|
|
KCNJ5
|
potassium channel, inwardly rectifying subfamily J, member 5
|
|
KCNMA1
|
potassium channel, calcium activated large conductance subfamily M alpha, member 1
|
|
KIR3DL1
|
killer cell immunoglobulin-like receptor, three domains, long cytoplasmic tail, 1
|
|
MIR106B
|
microRNA 106b
|
|
MMP2
|
matrix metallopeptidase 2
|
|
MMP9
|
matrix metallopeptidase 9
|
|
MPL
|
MPL proto-oncogene, thrombopoietin receptor
|
|
NPPC
|
natriuretic peptide C
|
|
NRG1
|
neuregulin 1
|
|
NUCB2
|
nucleobindin 2
|
|
PIGA
|
phosphatidylinositol glycan anchor biosynthesis, class A
|
|
PIGT
|
phosphatidylinositol glycan anchor biosynthesis, class T
|
|
PLA2G7
|
phospholipase A2, group VII (platelet-activating factor acetylhydrolase, plasma)
|
|
PLAU
|
plasminogen activator, urokinase
|
|
PNKD
|
paroxysmal nonkinesigenic dyskinesia
|
|
PRL
|
prolactin
|
|
PRNP
|
prion protein
|
|
PRRT2
|
proline-rich transmembrane protein 2
|
|
RYR2
|
ryanodine receptor 2 (cardiac)
|
|
SCN4A
|
sodium channel, voltage gated, type IV alpha subunit
|
|
SCN4B
|
sodium channel, voltage gated, type IV beta subunit
|
|
SCN5A
|
sodium channel, voltage gated, type V alpha subunit
|
|
SCN9A
|
sodium channel, voltage gated, type IX alpha subunit
|
|
SLC16A2
|
solute carrier family 16, member 2 (thyroid hormone transporter)
|
|
SLC2A1
|
solute carrier family 2 (facilitated glucose transporter), member 1
|
|
STAT5A
|
signal transducer and activator of transcription 5A
|
|
STAT5B
|
signal transducer and activator of transcription 5B
|
|
TBX5
|
T-box 5
|
|
TERC
|
telomerase RNA component
|
|
TIMP1
|
TIMP metallopeptidase inhibitor 1
|
|
TNFRSF11A
|
tumor necrosis factor receptor superfamily, member 11a, NFKB activator
|
|
TNFRSF11B
|
tumor necrosis factor receptor superfamily, member 11b
|
|
TNFSF11
|
tumor necrosis factor (ligand) superfamily, member 11
|
|
TNNI1
|
troponin I type 1 (skeletal, slow)
|
|
TNNI2
|
troponin I type 2 (skeletal, fast)
|
|
TNNI3
|
troponin I type 3 (cardiac)
|
|
VEGFA
|
vascular endothelial growth factor A
|
|
WT1
|
Wilms tumor 1
|
